Page last updated: 2024-10-31

minoxidil and Hospital-Acquired Condition

minoxidil has been researched along with Hospital-Acquired Condition in 1 studies

Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.

Research Excerpts

ExcerptRelevanceReference
"Thus, in patients with cancer, alopecia can be iatrogenic (chemotherapies, endocrine therapies, targeted therapies, immunotherapies, radiotherapy, surgery) or directly the consequence of the disease itself (malnutrition, scalp metastases, paraneoplastic syndromes)."2.72[Alopecia and cancers: From basics to clinical practice]. ( Baussard, L; Fiteni, F; Guichard, A; Le Vigouroux, S; Quesada, S, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Quesada, S1
Guichard, A1
Le Vigouroux, S1
Baussard, L1
Fiteni, F1

Reviews

1 review available for minoxidil and Hospital-Acquired Condition

ArticleYear
[Alopecia and cancers: From basics to clinical practice].
    Bulletin du cancer, 2021, Volume: 108, Issue:10

    Topics: Alopecia; Antihypertensive Agents; Antineoplastic Agents; Bimatoprost; Hair; Hair Follicle; Humans;

2021